Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
Revista Espanola De Enfermedades Digestivas
|
September 29, 2016
Specialist care in the management of inflammatory bowel disease
Carlos Taxonera Samso
Revista Espanola De Enfermedades Digestivas
|
July 28, 2017
Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
Carlos Taxonera, Pilar Robledo, Antonio Rodríguez
Inflammatory Bowel Diseases
|
February 15, 2021
Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
Carlos Taxonera, David Olivares, Cristina Alba
Revista Espanola De Enfermedades Digestivas
|
March 2, 2021
ABP 501 (adalimumab-atto) in the treatment of inflammatory bowel disease: an example of evidence-based extrapolation
Fernando Muñoz Núñez, Carlos Taxonera, Jordi Marrón
World Journal of Gastroenterology
|
September 15, 2009
Emerging treatments for complex perianal fistula in Crohn's disease
Carlos Taxonera, David A Schwartz, Damián García-Olmo
World Journal of Gastrointestinal Pathophysiology
|
June 28, 2012
Update on pathogenesis and clinical management of acute pancreatitis
Dulce M Cruz-Santamaría, Carlos Taxonera, Manuel Giner
Therapeutic Advances in Gastroenterology
|
August 13, 2020
Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review
Carlos Taxonera, Cristina Alba, Michel Colmenares, et al.
Alimentary Pharmacology & Therapeutics
|
January 16, 2023
Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis
Carlos Taxonera, David Olivares, Olga N López-García, et al.
Pathology, Research and Practice
|
November 7, 2017
Eosinophilic colitis: Case series and literature review
Cristina Díaz Del Arco, Carlos Taxonera, David Olivares, et al.
Alimentary Pharmacology & Therapeutics
|
May 3, 2020
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
Revista Espanola De Enfermedades Digestivas
|
September 29, 2016
Specialist care in the management of inflammatory bowel disease
Carlos Taxonera Samso
Revista Espanola De Enfermedades Digestivas
|
July 28, 2017
Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
Carlos Taxonera, Pilar Robledo, Antonio Rodríguez
Inflammatory Bowel Diseases
|
February 15, 2021
Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
Carlos Taxonera, David Olivares, Cristina Alba
Revista Espanola De Enfermedades Digestivas
|
March 2, 2021
ABP 501 (adalimumab-atto) in the treatment of inflammatory bowel disease: an example of evidence-based extrapolation
Fernando Muñoz Núñez, Carlos Taxonera, Jordi Marrón
World Journal of Gastroenterology
|
September 15, 2009
Emerging treatments for complex perianal fistula in Crohn's disease
Carlos Taxonera, David A Schwartz, Damián García-Olmo
World Journal of Gastrointestinal Pathophysiology
|
June 28, 2012
Update on pathogenesis and clinical management of acute pancreatitis
Dulce M Cruz-Santamaría, Carlos Taxonera, Manuel Giner
Therapeutic Advances in Gastroenterology
|
August 13, 2020
Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review
Carlos Taxonera, Cristina Alba, Michel Colmenares, et al.
Alimentary Pharmacology & Therapeutics
|
January 16, 2023
Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis
Carlos Taxonera, David Olivares, Olga N López-García, et al.
Pathology, Research and Practice
|
November 7, 2017
Eosinophilic colitis: Case series and literature review
Cristina Díaz Del Arco, Carlos Taxonera, David Olivares, et al.
Alimentary Pharmacology & Therapeutics
|
May 3, 2020
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, et al.
Page
of 12